RxDoctor Payments Data

Mohammed Ansari, MD

Nephrology · Chicago, ILNPI 1487688131

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $23,111 of the $25,362 with a category attached, or 91.1%. 5 manufacturers reported payments, led by Vertex at 45.0% of the total. Among nephrology clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$25,362in general payments, 2019–2025

Across 25 payments — averaging $1014.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Vertex$11K
  • Apellis Pharmaceuticals, Inc.$7K
  • Mallinckrodt Enterprises LLC$7K
  • Novartis$46
  • Covidien LP$21

What the payments were for

  • Consulting fees$23,11191%
  • Travel & lodging$1,9818%
  • Food & beverage$2711%

General payments by program year

19
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$25,362 in reported general payments places this provider in the 90th percentile of 524 nephrology providers in Illinois.

See all nephrology providers in Illinois

Medicare billing

Part B allowed, 2024
$85,553
Medicare patients
340
Services billed
1,120

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cinacalcet Hcl74$29,772
Tacrolimus63$10,479
Atovaquone13$9,205
Mycophenolate Mofetil56$8,205
RetacritEpoetin Alfa-Epbx12$8,181
EliquisApixaban12$7,805
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim456$2,530
Nifedipine ErNifedipine67$1,824
Mycophenolic AcidMycophenolate Sodium11$1,143
Losartan Potassium79$1,083
Carvedilol119$1,065
Leflunomide18$942
Prednisone98$893
Valganciclovir Hcl11$761
Bumetanide21$743

Paid to pharmacies, not to this prescriber.

Other nephrology in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →